- In a New York Magazine article, MSKCC’s Dr. Robert C. Kurtz explores the topic of whether or not soy milk is healthier than skim milk.
- A press release posted on MarketWatch announced that the Center for Medical Technology Policy (CMTP) published its official Effectiveness Guidance Document for how to better incorporate patient-reported outcomes into studies that enroll adult cancer patients. This guidance was developed in collaboration with Dr. Ethan Basch, of MSKCC, Dr. Amy Abernethy, MD, of Duke Cancer institute, and an expert working group of patient advocates, oncologists, researchers and life sciences and other experts.
- Dr. Clifford A. Hudis of MSKCC is quoted in a New York Times article about a drug, known as T-DM1, which delivers a powerful poison to tumors without some of the side effects of traditional treatments and also appears to substantially prolong lives.